FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Singulair news from FiercePharma

News

FDA nixes Merck, Schering allergy combo

In another blow to the Merck/Schering-Plough joint venture, the FDA rejected a proposed allergy and asthma treatment that would have Read more...

Under pharma earnings, basic problems

You've heard of see-through buildings. How about see-through pharma earnings? Though drug makers have been reporting increases to their bottom lines, investors are looking past the foreign-currency Read more...

Emerging markets drive global growth

Without emerging healthcare markets like China and India, global pharma would be in a world of hurt. The global market for meds reached $712 billion last year, according to a new report from IMS Read more...

FDA issues early-warning trifecta

It was a busy day yesterday for FDA safety reviews, with a trifecta of announcements raising questions about drugs for everything from allergies to HIV. They're all "early communications," which Read more...
Tags: Singulair  

Merck expects $1.8B hit on Fosamax

We all knew that losing patent protection on Fosamax would cut into Merck's sales next year. We just didn't know how much. Now we do, or at least we know Merck's best estimate: about $1.8 billion. Read more...
Tags: Fosamax   Merck   Singulair   analysts  

SPOTLIGHT: Merck profits jump by 62 percent

Merck & Co. saw its profits soar by 62 percent to $1.53 billion, on a 12 percent jump in revenue and lower admin and overhead costs; Singulair was the big seller for the quarter at $1 billion. Read more...
Tags: Merck   Singulair   profits  

Merck, Schering to combine blockbusters

Why not build on success? Schering-Plough and Merck are asking the FDA to approve a pill Read more...

Press Releases

PRESS RELEASE: Schering-Plough/Merck Announce FDA Filing Acceptance of NDA for Loratadine/Montelukast Tablet

Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet KENILWORTH and WHITEHOUSE STATION, N.J., Aug. 28 -- Read more...

Get more Singulair coverage at: